Mkts

Phathom Pharmaceuticals, Inc.

NASDAQ: PHAT
$5.99-0.07 (-1.16%)
As of Nov 16, 1:05 PM ET

Key statistics

Day range
5.766.15
52-week range
5.0118.31
Today
Open6.04
Previous close5.99
Volume—
Valuation
Market cap492.63M
P/E ratio—
EPS (TTM)-1.03
Income & risk
Dividend / yield—
Beta0.58
Avg volume1.49M
Discussion

PHAT News

Stories mentioning PHAT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue58,30157,58449,50439,50328,51929,66416,3527,324
Cost of Goods Sold11,9967,6476,1905,0383,7243,8152,3561,376
Gross Profit46,30549,93743,31434,46524,79525,84913,9965,948
Operating Expenses
Research & Development7,7717,4937,0279,0769,1848,5838,6937,376
Sales General & Admin54,01148,37251,55885,31394,47476,68376,09975,872
Total Operating Expenses61,78255,86558,58594,389103,65885,26684,79283,248
Operating Income (Loss)(15,477)(5,928)(15,271)(59,924)(78,863)(59,417)(70,796)(77,300)
Interest Income1,7361,2041,4131,7872,6403,5103,7113,624
Interest Expense17,764
Other Expense(831.00)(6.00)(7.00)(155.00)(22.00)49.00(8.00)(6.00)
Pretax Income
Tax Provision
Net Income (Loss)(30,369)(21,148)(29,973)(75,810)(94,316)(74,451)(85,577)(91,446)
Earnings Per Share (Basic)(0.37)(0.29)(0.41)(1.05)(1.31)(1.18)(1.32)(1.56)
Earnings Per Share (Diluted)(0.37)(0.29)(0.41)(1.05)(1.31)(1.18)(1.32)(1.56)
Weighted Average Shares Outstanding (Basic)82,05172,91973,39672,46671,96963,17664,62858,558
Weighted Average Shares Outstanding (Diluted)82,05172,91973,39672,46671,96963,17664,62858,558

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About PHAT

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is a stock listed on the Nasdaq Stock Market under the ticker symbol PHAT. It last traded at $5.99 (Nov 16, 2026, 1:05 PM ET), down 1.2% on the day. That gives Phathom Pharmaceuticals a market capitalisation of $492.6M.

Over the past 52 weeks PHAT has traded between $5.01 and $18.31.

Revenue for the quarter ended Mar 31, 2026 was $58.3M; a net loss of $30.4M. Revenue was up 104% from $28.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$58.3M-$30.4M-52.1%
Dec 31, 2025$57.6M-$21.1M-36.7%
Sep 30, 2025$49.5M-$30.0M-60.5%
Jun 30, 2025$39.5M-$75.8M-191.9%

From Phathom Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…